Gerda M. Sanvee
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: April 22, 2025
Imatinib disturbs lysosomal function and morphology and impairs the activity of mTORC1 in human hepatocyte cell lines.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: October 24, 2021
mTORC2 is an important target for simvastatin-associated toxicity in C2C12 cells and mouse skeletal muscle - Roles of Rap1 geranylgeranylation and mitochondrial dysfunction.
Journal: Biochemical pharmacology
Published: July 05, 2021
C2C12 myoblasts are more sensitive to the toxic effects of simvastatin than myotubes and show impaired proliferation and myotube formation.
Journal: Biochemical pharmacology
Published: April 30, 2021
Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts.
Journal: International journal of molecular sciences
Published: January 31, 2019
Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.
Journal: Biochemical pharmacology
Published: January 11, 2019
Mechanisms of statin-associated skeletal muscle-associated symptoms.
Journal: Pharmacological research
Published: January 03, 2019
Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells.
Journal: Scientific reports
Published: December 03, 2018
IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubes.
Journal: Archives of toxicology
Published: June 27, 2016
The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity.
Journal: Biochimica et biophysica acta
Published: December 20, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026